Multifunctional Gold Nanozyme‐Engineered Amphotericin B for Enhanced Antifungal Infection Therapy
Small · 2024
DOI: 10.1002/smll.202312253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Chunmei Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Space Bioscience and Space Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, 710072, …. Hauptthemen laut MEDLINE: Gold, Antifungal Agents, Amphotericin B, Metal Nanoparticles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key R&D Project in Shaanxi Province.
Abstract (Originalsprache)
Chronic wounds of significant severity and acute injuries are highly vulnerable to fungal infections, drastically impeding the expected wound healing trajectory. The clinical use of antifungal therapeutic drug is hampered by poor solubility, high toxicity and adverse reactions, thereby necessitating the urgent development of novel antifungal therapy strategy. Herein, this study proposes a new strategy to enhance the bioactivity of small‐molecule antifungal drugs based on multifunctional metal nanozyme engineering, using amphotericin B (AmB) as an example. AmB‐decorated gold nanoparticles (AmB@AuNPs) are synthesized by a facile one‐pot reaction strategy, and the AmB@AuNPs exhibit superior peroxidase (POD)‐like enzyme activity, with maximal reaction rates (V max ) 3.4 times higher than that of AuNPs for the catalytic reaction of H 2 O 2 . Importantly, the enzyme‐like activity of AuNPs significantly enhanced the antifungal properties of AmB, and the minimum inhibitory concentrations of AmB@AuNPs against Candida albicans ( C. albicans ) and Saccharomyces cerevisiae ( S. cerevisiae ) W303 are reduced by 1.6‐fold and 50‐fold, respectively, as compared with AmB alone. Concurrent in vivo studies conducted on fungal‐infected wounds in mice underscored the fundamentally superior antifungal ability and biosafety of AmB@AuNPs. The proposed strategy of engineering antifungal drugs with nanozymes has great potential for enhanced therapy of fungal infections and related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Space Bioscience and Space Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, 710072, China.
- State Key Laboratory of Solidification Processing, School of Materials Science and Engineering, Northwestern Polytechnical University, Xi'an, Shaanxi, 710072, China.
ORCID-Profile: Li Shang
Förderung
- National Natural Science Foundation of China
- Key R&D Project in Shaanxi Province
Zitieren
APA
Jiang, C., Li, F., Song, P., Wen, M., Yang, S., Tian, G., Shao, D., Shi, J., & Shang, L. (2024). Multifunctional Gold Nanozyme‐Engineered Amphotericin B for Enhanced Antifungal Infection Therapy. Small. https://doi.org/10.1002/smll.202312253
Vancouver
Jiang C, Li F, Song P, Wen M, Yang S, Tian G, et al. Multifunctional Gold Nanozyme‐Engineered Amphotericin B for Enhanced Antifungal Infection Therapy. Small. 2024. doi:10.1002/smll.202312253
BibTeX
@article{Jiang2024,
author = {Jiang, Chunmei and Li, Fangping and Song, Pei and Wen, Mengyao and Yang, Saixue and Tian, Geng and Shao, Dongyan and Shi, Junling and Shang, Li},
title = {Multifunctional Gold Nanozyme‐Engineered Amphotericin B for Enhanced Antifungal Infection Therapy},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202312253}
}
EUVIMED